Vimarsana
Biggest News Aggregation in the World

Entry Inhibitor Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Entry Inhibitor Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Entry Inhibitor Program Today - Breaking & Trending Today

Assembly Biosciences to Highlight Pipeline Progress in HBV and HDV at the 2023 International HBV Meeting - Vimarsana News

Assembly Biosciences to Highlight Pipeline Progress in HBV and HDV at the 2023 International HBV Meeting

Published: September 19, 2023

-- Two oral presentations and one poster will feature new data from the Company’s hepatitis B/hepatitis D entry inhibitor, capsid assembly modulator ABI-4334, and interferon-alpha receptor agonist...

Source: marketscreener.com
Related Topics:
Marcp WindischWilliam DelaneyShannon RyanNuruddin UnchwaniwalaAssembly Biosciences IncEntry Inhibitor ProgramAssembly BioRisk Factors In Assembly BioCorporate AffairsSecurities ExchangeSam Brown IncAssembly BiosciencesExchange CommissionAlliance ManagementReceptor AgonistSecurities ActSecurities Exchange ActAnnual ReportQuarterly ReportsCurrent ReportsInvestor Relations
Assembly Biosciences Presents New Data Highlighting Entry Inhibitor and Core Inhibitor Programs at EASL's International Liver Congress™ 2023 - Vimarsana News

Assembly Biosciences Presents New Data Highlighting Entry Inhibitor and Core Inhibitor Programs at EASL's International Liver Congress™ 2023

Published: June 21, 2023

SOUTH SAN FRANCISCO, Calif., June 21, 2023 -- Assembly Biosciences, Inc. , a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today... | June 21, 2023

Source: marketscreener.com
Related Topics:
William DelaneyShannon RyanExchange CommissionSam Brown IncCorporate AffairsInternational Liver CongressAlliance ManagementAssembly BioSecurities ExchangeRisk Factors In Assembly BioAssembly BiosciencesEntry Inhibitor ProgramAssembly Biosciences IncAnnual MeetingEuropean AssociationInhibitor ProgramInhibitor CandidatesLiver CongressSecurities ActSecurities Exchange ActAnnual ReportQuarterly ReportsCurrent ReportsInvestor Relations